CP-547632 manufacturers
- CP-547632
-
- $30.00 / 1mg
-
2024-11-19
- CAS:252003-65-9
- Min. Order:
- Purity: 98.51%
- Supply Ability: 10g
- CP-547632
-
- $30.00 / 1mg
-
2024-11-19
- CAS:252003-65-9
- Min. Order:
- Purity: 98.51%
- Supply Ability: 10g
- CP-547632
-
- $1.00 / 1g
-
2020-01-13
- CAS:252003-65-9
- Min. Order: 1g
- Purity: 95-99%
- Supply Ability: 1ton
|
| CP-547632 Basic information |
Product Name: | CP-547632 | Synonyms: | CP-547632;3-(4-Bromo-2,6-difluorobenzyloxy)-5-(3-(4-pyrrolidin-1-ylbutyl)ureido)isothiazole-4-carboxylic acid amide;4-Isothiazolecarboxamide, 3-((4-bromo-2,6-difluorophenyl)methoxy)-5-((((4-(1-pyrrolidinyl)butyl)amino)carbonyl)amino)-;CP-547632(CP 547632);3-[(4-broMo-2,6-difluorophenyl)Methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]aMino]carbonyl]aMino]-4-isothiazolecarboxaMide;3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxami;3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carbox;3-[(4-Bromo-2,6-difluorobenzyl)oxy]-5-[3-[4-(pyrrolidin-1-yl)butyl]ureido]isothiazole-4-carboxamide | CAS: | 252003-65-9 | MF: | C20H24BrF2N5O3S | MW: | 532.4 | EINECS: | 200-258-5 | Product Categories: | | Mol File: | 252003-65-9.mol | |
| CP-547632 Chemical Properties |
Boiling point | 548.6±50.0 °C(Predicted) | density | 1.532 | storage temp. | 2-8°C | solubility | DMSO: 94 mM | form | A solid | pka | 12.50±0.70(Predicted) | color | White to light yellow |
| CP-547632 Usage And Synthesis |
Description | CP 547,632 is an orally bioavailable and potent inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) with IC50 values of 11 and 9 nM, respectively, in an enzyme assay. It is selective for VEGFR2 and bFGF over EGFR, PDGF receptor β (PDGFRβ), and related tyrosine kinases. CP 547,632 inhibits VEGFR2 autophosphorylation induced by VEGF in porcine aortic endothelial cells transfected with VEGFR2 (IC50 = 6 nM) and in a xenograft mouse model using NIH3T3/H-Ras cells (EC50 = 590 nM). It decreases angiogenesis induced by VEGF or bFGF and suppresses tumor growth in athymic mice. |
| CP-547632 Preparation Products And Raw materials |
|